Acquisition of Human Concentrative Nucleoside Transporter 2 (hCNT2) Activity by Gene Transfer Confers Sensitivity to Fluoropyrimidine Nucleosides in Drug-Resistant Leukemia Cells
- 1 November 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 60 (5) , 1143-1152
- https://doi.org/10.1124/mol.60.5.1143
Abstract
CEM-ARAC leukemia cells with resistance to cytarabine were shown to lack equilibrative transporter (hENT1) expression and activity. Stable transfer of hCNT2 cDNA into CEM-ARAC enabled Na+-dependent transport of purine and pyrimidine nucleoside analogs and provided a unique in vitro model for studying hCNT2. Analysis of [3H]uridine inhibitory activity by test substances in hCNT2 transfectant ARAC/D2 revealed structural requirements for interaction with hCNT2: 1) ribosyl and 2′-deoxyribosyl nucleosides were better inhibitors than 3′-deoxyribosyl, 2′,3′-dideoxyribosyl or arabinosyl nucleosides; 2) uridine analogs with halogens at position 5 were better inhibitors than 5-methyluridine or thymidine; 3) 2-chloroadenosine was a better inhibitor than 2-chloro-2′-deoxyadenosine (cladribine); and 4) cytosine-containing nucleosides, 7-deazaadenosine and nucleobases were not inhibitors. Quantification of inhibitory capacity yieldedKi values of 34–50 μM (5-halogenated uridine analogs, 2′-deoxyuridine), 82 μM (5-fluoro-2′-deoxyuridine), 197–246 μM (5-methyluridine < 5-bromo-2′-deoxyuridine < 5-iodo-2′-deoxyuridine), and 411 μM (5-fluoro-5′-deoxyuridine, capecitabine metabolite). Comparisons of hCNT2-mediated transport rates indicated halogenated uridine analogs were transported more rapidly than halogenated adenosine analogs, even though hCNT2 exhibited preference for physiologic purine nucleosides over uridine. Kinetics of hCNT2-mediated transport of 5-fluorouridine and uridine were similar (Km values, 43–46 μM). The impact of hCNT2-mediated transport on chemosensitivity was assessed by comparing antiproliferative activity of nucleoside analogs against hCNT2-containing cells with transport-defective, drug-resistant cells. Chemosensitivity was restored partially for cladribine, completely for 5-fluorouridine and 5-fluoro-2′-deoxyuridine, whereas there was little effect on chemosensitivity for fludarabine, 7-deazaadenosine, or cytarabine. These studies, which demonstrated hCNT2 uptake of halogenated uridine analogs, suggested that hCNT2 is an important determinant of cytotoxicity of this class of compounds in vivo.Keywords
This publication has 36 references indexed in Scilit:
- Continuous delivery of venous 5-fluorpuracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancerAnti-Cancer Drugs, 1999
- Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell LinePublished by Elsevier ,1998
- Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridineMolecular Membrane Biology, 1998
- Recent advances in the molecular biology of nucleoside transporters of mammalian cellsBiochemistry and Cell Biology, 1998
- Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell lineBiochemistry and Cell Biology, 1998
- Nucleoside and nucleobase transport systems of mammalian cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1996
- Nucleoside transport in brush border membrane vesicles from human kidneyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblastThe Journal of Membrane Biology, 1991
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJournal of Clinical Investigation, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973